Article
Predicting T790M mutation status in non-small cell lung cancer based on radiomics: A systematic review and meta-analysis.
PloS one - 1 Jan 2026
Chen Hongyang, Fan Bingjie, Yuan Mengqi, Wang Dandan, Qiao Chenxi, Qiu Na, Quan Xiaomin, Hou Wei
Abstract excerpt
BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have revolutionized the prognosis for patients with EGFR-mutant lung cancer. The emergence of the T790M resistance mutation compromises the efficacy of EGFR-TKI therapy. Therefore, assessing EGFR T790M mutation status during non-small cell lung cancer (NSCLC) treatment is crucial for improving NSCLC prognosis. METHOD: PubMed,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
